CTLA4 and arthritic joint disease: It has therefore been used widely in the treatment of irAE-arthritis (from CTLA-4, PD-1, or PD-L1 inhibitors alone or in combination) in patients in whom from glucocorticoids cannot be tapered successfully (24).